Annals of the Rheumatic Diseases Issues Research Articles in March 2022 Edition
February 14, 2022
February 14, 2022
LONDON, England, Feb. 14 -- Annals of the Rheumatic Diseases, a peer-reviewed journal that says it covers rheumatology, including musculoskeletal conditions, arthritic disease and connective tissue disorders, published research articles on the following topics in its March 2022 edition:
RHEUMATOID ARTHRITIS:
* Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension stu . . .
RHEUMATOID ARTHRITIS:
* Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension stu . . .